Literature DB >> 23640534

How effective are the current treatments for children diagnosed with manic/mixed bipolar disorder?

Benedetto Vitiello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23640534     DOI： 10.1007/s40263-013-0060-3

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  11 in total

1.  The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys.

Authors:  Karl-Anton Dorph-Petersen; Joseph N Pierri; James M Perel; Zhuoxin Sun; Allan R Sampson; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

2.  A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.

Authors:  Barbara Geller; Joan L Luby; Paramjit Joshi; Karen Dineen Wagner; Graham Emslie; John T Walkup; David A Axelson; Kristine Bolhofner; Adelaide Robb; Dwight V Wolf; Mark A Riddle; Boris Birmaher; Nasima Nusrat; Neal D Ryan; Benedetto Vitiello; Rebecca Tillman; Philip Lavori
Journal:  Arch Gen Psychiatry       Date:  2012-01-02

Review 3.  Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.

Authors:  David Fraguas; Christoph U Correll; Jessica Merchán-Naranjo; Marta Rapado-Castro; Mara Parellada; Carmen Moreno; Celso Arango
Journal:  Eur Neuropsychopharmacol       Date:  2010-08-10       Impact factor: 4.600

4.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Authors:  Beng-Choon Ho; Nancy C Andreasen; Steven Ziebell; Ronald Pierson; Vincent Magnotta
Journal:  Arch Gen Psychiatry       Date:  2011-02

5.  Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.

Authors:  Benedetto Vitiello; Mark A Riddle; Gayane Yenokyan; David A Axelson; Karen D Wagner; Paramjit Joshi; John T Walkup; Joan Luby; Boris Birmaher; Neal D Ryan; Graham Emslie; Adelaide Robb; Rebecca Tillman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-07-31       Impact factor: 8.829

6.  A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.

Authors:  Karen Dineen Wagner; Laura Redden; Robert A Kowatch; Timothy E Wilens; Scott Segal; Kiki Chang; Patricia Wozniak; Namita V Vigna; Walid Abi-Saab; Mario Saltarelli
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-05       Impact factor: 8.829

7.  Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation.

Authors:  Anthony C Vernon; Sridhar Natesan; Mike Modo; Shitij Kapur
Journal:  Biol Psychiatry       Date:  2010-12-31       Impact factor: 13.382

Review 8.  Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.

Authors:  Andrea Cipriani; Corrado Barbui; Georgia Salanti; Jennifer Rendell; Rachel Brown; Sarah Stockton; Marianna Purgato; Loukia M Spineli; Guy M Goodwin; John R Geddes
Journal:  Lancet       Date:  2011-08-16       Impact factor: 79.321

Review 9.  Mood dysregulation.

Authors:  Nina Mikita; Argyris Stringaris
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-02       Impact factor: 4.785

10.  The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation.

Authors:  Robert L Findling; Jean A Frazier; Vivian Kafantaris; Robert Kowatch; Jon McClellan; Mani Pavuluri; Linmarie Sikich; Stefanie Hlastala; Stephen R Hooper; Christine A Demeter; Denise Bedoya; Bernard Brownstein; Perdita Taylor-Zapata
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-08-12       Impact factor: 3.033
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.